1 Introduction to Research & Analysis Reports
1.1 Medical Antifungal Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Antifungal Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Antifungal Agent Overall Market Size
2.1 Global Medical Antifungal Agent Market Size: 2022 VS 2029
2.2 Global Medical Antifungal Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Antifungal Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Antifungal Agent Players in Global Market
3.2 Top Global Medical Antifungal Agent Companies Ranked by Revenue
3.3 Global Medical Antifungal Agent Revenue by Companies
3.4 Global Medical Antifungal Agent Sales by Companies
3.5 Global Medical Antifungal Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Antifungal Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Antifungal Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Antifungal Agent Players in Global Market
3.8.1 List of Global Tier 1 Medical Antifungal Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Antifungal Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Antifungal Agent Market Size Markets, 2022 & 2029
4.1.2 Azoles
4.1.3 Echinocandins
4.1.4 Polyenes
4.1.5 Allylamines
4.1.6 Others
4.2 By Type – Global Medical Antifungal Agent Revenue & Forecasts
4.2.1 By Type – Global Medical Antifungal Agent Revenue, 2018-2023
4.2.2 By Type – Global Medical Antifungal Agent Revenue, 2024-2029
4.2.3 By Type – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
4.3 By Type – Global Medical Antifungal Agent Sales & Forecasts
4.3.1 By Type – Global Medical Antifungal Agent Sales, 2018-2023
4.3.2 By Type – Global Medical Antifungal Agent Sales, 2024-2029
4.3.3 By Type – Global Medical Antifungal Agent Sales Market Share, 2018-2029
4.4 By Type – Global Medical Antifungal Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Antifungal Agent Market Size, 2022 & 2029
5.1.2 Dermatophytosis
5.1.3 Aspergillosis
5.1.4 Candidiasis
5.1.5 Others
5.2 By Application – Global Medical Antifungal Agent Revenue & Forecasts
5.2.1 By Application – Global Medical Antifungal Agent Revenue, 2018-2023
5.2.2 By Application – Global Medical Antifungal Agent Revenue, 2024-2029
5.2.3 By Application – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
5.3 By Application – Global Medical Antifungal Agent Sales & Forecasts
5.3.1 By Application – Global Medical Antifungal Agent Sales, 2018-2023
5.3.2 By Application – Global Medical Antifungal Agent Sales, 2024-2029
5.3.3 By Application – Global Medical Antifungal Agent Sales Market Share, 2018-2029
5.4 By Application – Global Medical Antifungal Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Antifungal Agent Market Size, 2022 & 2029
6.2 By Region – Global Medical Antifungal Agent Revenue & Forecasts
6.2.1 By Region – Global Medical Antifungal Agent Revenue, 2018-2023
6.2.2 By Region – Global Medical Antifungal Agent Revenue, 2024-2029
6.2.3 By Region – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
6.3 By Region – Global Medical Antifungal Agent Sales & Forecasts
6.3.1 By Region – Global Medical Antifungal Agent Sales, 2018-2023
6.3.2 By Region – Global Medical Antifungal Agent Sales, 2024-2029
6.3.3 By Region – Global Medical Antifungal Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical Antifungal Agent Revenue, 2018-2029
6.4.2 By Country – North America Medical Antifungal Agent Sales, 2018-2029
6.4.3 US Medical Antifungal Agent Market Size, 2018-2029
6.4.4 Canada Medical Antifungal Agent Market Size, 2018-2029
6.4.5 Mexico Medical Antifungal Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical Antifungal Agent Revenue, 2018-2029
6.5.2 By Country – Europe Medical Antifungal Agent Sales, 2018-2029
6.5.3 Germany Medical Antifungal Agent Market Size, 2018-2029
6.5.4 France Medical Antifungal Agent Market Size, 2018-2029
6.5.5 U.K. Medical Antifungal Agent Market Size, 2018-2029
6.5.6 Italy Medical Antifungal Agent Market Size, 2018-2029
6.5.7 Russia Medical Antifungal Agent Market Size, 2018-2029
6.5.8 Nordic Countries Medical Antifungal Agent Market Size, 2018-2029
6.5.9 Benelux Medical Antifungal Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical Antifungal Agent Revenue, 2018-2029
6.6.2 By Region – Asia Medical Antifungal Agent Sales, 2018-2029
6.6.3 China Medical Antifungal Agent Market Size, 2018-2029
6.6.4 Japan Medical Antifungal Agent Market Size, 2018-2029
6.6.5 South Korea Medical Antifungal Agent Market Size, 2018-2029
6.6.6 Southeast Asia Medical Antifungal Agent Market Size, 2018-2029
6.6.7 India Medical Antifungal Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical Antifungal Agent Revenue, 2018-2029
6.7.2 By Country – South America Medical Antifungal Agent Sales, 2018-2029
6.7.3 Brazil Medical Antifungal Agent Market Size, 2018-2029
6.7.4 Argentina Medical Antifungal Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Antifungal Agent Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical Antifungal Agent Sales, 2018-2029
6.8.3 Turkey Medical Antifungal Agent Market Size, 2018-2029
6.8.4 Israel Medical Antifungal Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Antifungal Agent Market Size, 2018-2029
6.8.6 UAE Medical Antifungal Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Medical Antifungal Agent Major Product Offerings
7.1.4 Novartis Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Medical Antifungal Agent Major Product Offerings
7.2.4 Pfizer Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Medical Antifungal Agent Major Product Offerings
7.3.4 Bayer Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Medical Antifungal Agent Major Product Offerings
7.4.4 Sanofi Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Merck & Co
7.5.1 Merck & Co Company Summary
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Medical Antifungal Agent Major Product Offerings
7.5.4 Merck & Co Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Medical Antifungal Agent Major Product Offerings
7.6.4 GlaxoSmithKline Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 MSD Manuals
7.7.1 MSD Manuals Company Summary
7.7.2 MSD Manuals Business Overview
7.7.3 MSD Manuals Medical Antifungal Agent Major Product Offerings
7.7.4 MSD Manuals Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.7.5 MSD Manuals Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Medical Antifungal Agent Major Product Offerings
7.8.4 Abbott Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 Glenmark
7.9.1 Glenmark Company Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Medical Antifungal Agent Major Product Offerings
7.9.4 Glenmark Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.9.5 Glenmark Key News & Latest Developments
7.10 Enzon Pharmaceuticals
7.10.1 Enzon Pharmaceuticals Company Summary
7.10.2 Enzon Pharmaceuticals Business Overview
7.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Major Product Offerings
7.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.10.5 Enzon Pharmaceuticals Key News & Latest Developments
7.11 Astellas Pharma
7.11.1 Astellas Pharma Company Summary
7.11.2 Astellas Pharma Medical Antifungal Agent Business Overview
7.11.3 Astellas Pharma Medical Antifungal Agent Major Product Offerings
7.11.4 Astellas Pharma Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.11.5 Astellas Pharma Key News & Latest Developments
7.12 Scynexis
7.12.1 Scynexis Company Summary
7.12.2 Scynexis Medical Antifungal Agent Business Overview
7.12.3 Scynexis Medical Antifungal Agent Major Product Offerings
7.12.4 Scynexis Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.12.5 Scynexis Key News & Latest Developments
7.13 Cidara Therapeutics
7.13.1 Cidara Therapeutics Company Summary
7.13.2 Cidara Therapeutics Medical Antifungal Agent Business Overview
7.13.3 Cidara Therapeutics Medical Antifungal Agent Major Product Offerings
7.13.4 Cidara Therapeutics Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.13.5 Cidara Therapeutics Key News & Latest Developments
7.14 Lucigen Corporation
7.14.1 Lucigen Corporation Company Summary
7.14.2 Lucigen Corporation Business Overview
7.14.3 Lucigen Corporation Medical Antifungal Agent Major Product Offerings
7.14.4 Lucigen Corporation Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.14.5 Lucigen Corporation Key News & Latest Developments
7.15 Biosergen
7.15.1 Biosergen Company Summary
7.15.2 Biosergen Business Overview
7.15.3 Biosergen Medical Antifungal Agent Major Product Offerings
7.15.4 Biosergen Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.15.5 Biosergen Key News & Latest Developments
7.16 F2G
7.16.1 F2G Company Summary
7.16.2 F2G Business Overview
7.16.3 F2G Medical Antifungal Agent Major Product Offerings
7.16.4 F2G Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.16.5 F2G Key News & Latest Developments
7.17 Sichuan Meidakang Pharmaceutical
7.17.1 Sichuan Meidakang Pharmaceutical Company Summary
7.17.2 Sichuan Meidakang Pharmaceutical Business Overview
7.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Major Product Offerings
7.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.17.5 Sichuan Meidakang Pharmaceutical Key News & Latest Developments
7.18 Chengdu Taihe Health Technology
7.18.1 Chengdu Taihe Health Technology Company Summary
7.18.2 Chengdu Taihe Health Technology Business Overview
7.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Major Product Offerings
7.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.18.5 Chengdu Taihe Health Technology Key News & Latest Developments
8 Global Medical Antifungal Agent Production Capacity, Analysis
8.1 Global Medical Antifungal Agent Production Capacity, 2018-2029
8.2 Medical Antifungal Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Antifungal Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Antifungal Agent Supply Chain Analysis
10.1 Medical Antifungal Agent Industry Value Chain
10.2 Medical Antifungal Agent Upstream Market
10.3 Medical Antifungal Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Antifungal Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の医療用抗真菌剤市場予測2023-2029：アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他 |
| 【英語タイトル】Medical Antifungal Agent Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5743 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：114 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥474,500 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥616,850 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥711,750 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の医療用抗真菌剤市場規模と予測を収録しています。・世界の医療用抗真菌剤市場：売上、2018年-2023年、2024年-2029年 ・世界の医療用抗真菌剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の医療用抗真菌剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アゾール類」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 医療用抗真菌剤のグローバル主要企業は、Novartis、 Pfizer、 Bayer、 Sanofi、 Merck & Co、 GlaxoSmithKline、 MSD Manuals、 Abbott、 Glenmark、 Enzon Pharmaceuticals、 Astellas Pharma、 Scynexis、 Cidara Therapeutics、 Lucigen Corporation、 Biosergen、 F2G、 Sichuan Meidakang Pharmaceutical、 Chengdu Taihe Health Technologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、医療用抗真菌剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の医療用抗真菌剤市場：タイプ別、2018年-2023年、2024年-2029年 世界の医療用抗真菌剤市場：タイプ別市場シェア、2022年 ・アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他 世界の医療用抗真菌剤市場：用途別、2018年-2023年、2024年-2029年 世界の医療用抗真菌剤市場：用途別市場シェア、2022年 ・皮膚糸状菌症、アスペルギルス症、カンジダ症、その他 世界の医療用抗真菌剤市場：地域・国別、2018年-2023年、2024年-2029年 世界の医療用抗真菌剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における医療用抗真菌剤のグローバル売上、2018年-2023年 ・主要企業における医療用抗真菌剤のグローバル売上シェア、2022年 ・主要企業における医療用抗真菌剤のグローバル販売量、2018年-2023年 ・主要企業における医療用抗真菌剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis、 Pfizer、 Bayer、 Sanofi、 Merck & Co、 GlaxoSmithKline、 MSD Manuals、 Abbott、 Glenmark、 Enzon Pharmaceuticals、 Astellas Pharma、 Scynexis、 Cidara Therapeutics、 Lucigen Corporation、 Biosergen、 F2G、 Sichuan Meidakang Pharmaceutical、 Chengdu Taihe Health Technology ************************************************************* ・調査・分析レポートの概要 医療用抗真菌剤市場の定義 市場セグメント 世界の医療用抗真菌剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の医療用抗真菌剤市場規模 世界の医療用抗真菌剤市場規模：2022年 VS 2029年 世界の医療用抗真菌剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの医療用抗真菌剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の医療用抗真菌剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他 医療用抗真菌剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：皮膚糸状菌症、アスペルギルス症、カンジダ症、その他 医療用抗真菌剤の用途別グローバル売上・予測 ・地域別市場分析 地域別医療用抗真菌剤市場規模 2022年と2029年 地域別医療用抗真菌剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis、 Pfizer、 Bayer、 Sanofi、 Merck & Co、 GlaxoSmithKline、 MSD Manuals、 Abbott、 Glenmark、 Enzon Pharmaceuticals、 Astellas Pharma、 Scynexis、 Cidara Therapeutics、 Lucigen Corporation、 Biosergen、 F2G、 Sichuan Meidakang Pharmaceutical、 Chengdu Taihe Health Technology ... |
Antifungals are medicines that kill or stop the growth of fungi that cause infections.
This report aims to provide a comprehensive presentation of the global market for Medical Antifungal Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Antifungal Agent. This report contains market size and forecasts of Medical Antifungal Agent in global, including the following market information:
Global Medical Antifungal Agent Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Antifungal Agent Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Medical Antifungal Agent companies in 2022 (%)
The global Medical Antifungal Agent market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Azoles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medical Antifungal Agent include Novartis, Pfizer, Bayer, Sanofi, Merck & Co, GlaxoSmithKline, MSD Manuals, Abbott and Glenmark, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Antifungal Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Antifungal Agent Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Antifungal Agent Market Segment Percentages, by Type, 2022 (%)
Azoles
Echinocandins
Polyenes
Allylamines
Others
Global Medical Antifungal Agent Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Antifungal Agent Market Segment Percentages, by Application, 2022 (%)
Dermatophytosis
Aspergillosis
Candidiasis
Others
Global Medical Antifungal Agent Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Antifungal Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Antifungal Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Antifungal Agent revenues share in global market, 2022 (%)
Key companies Medical Antifungal Agent sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Antifungal Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Antifungal Agent, market overview.
Chapter 2: Global Medical Antifungal Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Antifungal Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Antifungal Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Antifungal Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| ★調査レポート[世界の医療用抗真菌剤市場予測2023-2029：アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他] (コード：MMG23JU5743)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の医療用抗真菌剤市場予測2023-2029：アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他]についてメールでお問い合わせ |
